https://doi.org/10.1038/s41467-018-05032-8
N
Nikita Mani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
1.5K
Citations
13
h-index
17
i10-index
Nikita Mani is an academic researcher from Northwestern University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Immune Cell Function and Interaction. The author has an h-index of 13, co-authored 51 publications.
ORCID: 0000-0003-4688-7770Papers by this author
worksA dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
2018 · Nature Communications · 185 citations
Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer
2016 · Breast Cancer Research · 100 citations
https://doi.org/10.1186/s13058-016-0737-x
Loss of antigenicity with tissue age in breast cancer
2015 · Laboratory Investigation · 48 citations
https://doi.org/10.1038/labinvest.2015.138
Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis
2024 · iScience · 12 citations
https://doi.org/10.1016/j.isci.2024.110592
Mediator complex subunit 1 architects a tumorigenic Treg cell program independent of inflammation
2024 · Cell Reports Medicine · 4 citations
https://doi.org/10.1016/j.xcrm.2024.101441
Treg activation during allograft tolerance induction requires mitochondrion-induced TGF-β1 in type 1 conventional dendritic cells
2025 · Journal of Clinical Investigation · 3 citations
https://doi.org/10.1172/jci178960
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat